The early but significant progress in the first human stem cell therapy trial provides hope for a new approach in Alzheimer’s care, potentially aiding in brain healing. The Phase 1 study’s goal is to establish a recommended dose for a potential Phase 2 trial. Moving forward, Regeneration Biomedical aims to expand the therapy to other diseases like multiple sclerosis, Parkinson’s disease, traumatic brain injury, and amyotrophic lateral sclerosis, addressing unmet medical needs in these conditions.
Read more about this — theadvocate.com
